Saso Cemerski, PhD, is Senior Vice President, Head of Immunology at Marengo Therapeutics, where he leads immunology research across the company’s clinical and preclinical portfolio and helps shape the company’s scientific strategy. Dr. Cemerski brings deep expertise in leading immunology research and therapeutic discovery across biotechnology and pharmaceutical companies. Most recently, he served as Head of Discovery Immune Cell Engagement at AstraZeneca, where he led a global organization of more than 75 scientists, advanced multiple discovery programs toward clinical development, and helped evaluate and integrate externally sourced T-cell engager technologies. His prior experience includes a senior leadership role at Cue Biopharma, as well as positions at Merck, Bristol Myers Squibb and Xencor, where he contributed to the advancement of multiple antibody and small molecule therapeutics from discovery through clinical development.

Dr. Cemerski earned his PhD in Immunology from Université Paul Sabatier, Toulouse III, and completed postdoctoral training in immunology at Washington University in St. Louis.